Nav: Home

Rapidly assessing the next influenza pandemic

September 24, 2015

Influenza pandemics are potentially the most serious natural catastrophes that affect the human population. New findings published in PLOS Computational Biology suggest that with both timely and accurate data and sophisticated numerical models, the likely impact of a new pandemic can be assessed quickly, and key decisions made about potential mitigation strategies.

Novel strains of influenza emerge periodically and can pose major challenges for health planners. The 1918 Spanish flu, for example, was responsible for the deaths of some 50 million people. A recent 2015 report by the UK's Cabinet Office, National Risk Register of Civil Emergencies, identified Pandemic Influenza as the highest priority natural hazards risk. When faced with a new emerging strain of virus, policy makers would like to know: (1) how many people are going to be affected? (2) how severe will it be? And (3) what successful mitigation strategies can be implemented?

In a new study by a team of international researchers representing commercial, academic, and government institutions, these questions have been addressed through the study of a unique set of data from active duty personnel of the U.S. military and the development of a sophisticated mathematical model. The team focused on the 2009 pandemic (known as the "swine flu"). They created profiles of incidence from detailed recorded visits to military clinics for all major military installations. They also developed a tailor-made model to ingest these data and jointly estimate both the transmissibility of the pandemic as well as its severity.

Transmissibility is generally estimated through the parameter known as the basic reproductive number, R0, which is the average number of secondary cases generated by one typically infectious individual in an otherwise susceptible population. In other words, it is the number of people that an infectious person is likely to infect. For influenza, this is typically between 1.5-3. Severity can be estimated in a number of ways. For this study, the authors estimated the fraction of those infected who actually presented themselves to a clinic (pC).

The authors were able to demonstrate that timely data from early-infected military bases could inform the model and produce robust predictions for the later large-scale outbreak across the USA. Additionally, the model estimated the fraction of those with more serious conditions. While the 2009 pandemic was, in retrospect, a mild pandemic (R0 was estimated to be 1.35, and pC was estimated to be 7%), it served as an ideal test bed for developing a general predictive tool that can be applied in the early stages of a future pandemic.

To test the benefit of this approach, the authors simulated a future moderate pandemic strain with pC approximately 10 times that of 2009. The results showed that even before the peak had passed the first affected population, both R0 and pC could be well estimated and predicted for all populations. Additionally, they were able to show what the effects of mitigation strategies would be in terms of the total number of people infected and the severity of their infection.

The study highlighted the importance of: (1) using a two-dimensional space for assessing future novel respiratory pathogens (R0 and severity); (2) timely and accurate incidence data; and (3) the use of models specifically honed for the particular data being assessed.

The investigation was based on a large database of clinical visit data. Such databases are being constructed in many different countries at the moment. The fact that the analysis described in this paper could be conducted on any such database adds to the justification that these information resources should be generated in real-time and made available to the best data science tools.
-end-
All works published in PLOS Computational Biology are Open Access, which means that all content is immediately and freely available. Use this URL in your coverage to provide readers access to the paper upon publication: http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1004392

Contact: Pete Riley
Address: 9990 Mesa Rim Rd.
Suite 170
San Diego, CA 92124
UNITED STATES
Phone: 858-217-5868
Email: pete@predsci.com

Citation: Riley P, Ben-Nun M, Linker JA, Cost AA, Sanchez JL, George D, et al. (2015) Early Characterization of the Severity and Transmissibility of Pandemic Influenza Using Clinical Episode Data from Multiple Populations. PLoS Comput Biol 11(9):e1004392. doi:10.1371/journal.pcbi.1004392

Funding: Work performed by PR, MBN, JAL, DPB, and SR was supported by the Defense Threat Reduction Agency (DTRA), contract number: HDTRA1-14-C-0031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: PR, MBN, and JAL are paid employees of Predictive Science Inc. David P. Bacon is a paid employee of Leidos. The authors have declared that no other competing interests exist.

About PLOS Computational Biology

PLOS Computational Biology) features works of exceptional significance that further our understanding of living systems at all scales through the application of computational methods. All works published in PLOS Computational Biology are Open Access. All content is immediately available and subject only to the condition that the original authorship and source are properly attributed. Copyright is retained. For more information follow @PLOSCompBiol on Twitter or contact ploscompbiol@plos.org.

About PLOS

PLOS is a nonprofit publisher and advocacy organization founded to accelerate progress in science and medicine by leading a transformation in research communication. For more information, visit http://www.plos.org.

PLOS

Related Influenza Articles:

How proteins help influenza A bind and slice its way to cells
Researchers have provided new insight on how two proteins help influenza A virus particles fight their way to human cells.
Eating elderberries can help minimize influenza symptoms
Conducted by Professor Fariba Deghani, Dr. Golnoosh Torabian and Dr.
Mechanism to form influenza A virus discovered
A new study by Maria João Amorim's team, from the Gulbenkian Institute of Science, now reveals where the genomes of the influenza A virus are assembled inside infected cells.
Bat influenza viruses could infect humans
Bats don't only carry the deadly Ebola virus, but are also a reservoir for a new type of influenza virus.
New VaxArray publication on influenza neuraminidase quantification
InDevR Inc. announced publication of 'A Neuraminidase Potency Assay for Quantitative Assessment of Neuraminidase in Influenza Vaccines' in npj Vaccines.
Fighting mutant influenza
Another flu season is here, which means another chance for viruses to mutate.
Influenza vaccine delays are a problem for pediatricians
Uptake of influenza vaccine among children is low compared to other childhood vaccines, and missed opportunities for vaccination play an important role in this low uptake.
For a better influenza vaccine, focus on the neglected 'N'
In the April 5, 2018, issue of the journal Cell, researchers push for greater emphasis on the neglected viral-surface influenza protein neuraminidase.
Previous influenza virus exposures enhance susceptibility in another influenza pandemic
New data analysis suggests that people born at the time of the 1957 H2N2 or Asian Flu pandemic were at a higher risk of dying during the 2009 H1N1 Swine Flu pandemic as well as the resurgent H1N1 outbreak in 2013-2014.
Annual influenza vaccination does not prevent natural immunity
Earlier studies have suggested that having repeated annual influenza vaccination can prevent natural immunity to the virus, and potentially increase the susceptibility to influenza illness in the event of a pandemic, or when the vaccine does not 'match' the virus circulating in the community.
More Influenza News and Influenza Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Accessing Better Health
Essential health care is a right, not a privilege ... or is it? This hour, TED speakers explore how we can give everyone access to a healthier way of life, despite who you are or where you live. Guests include physician Raj Panjabi, former NYC health commissioner Mary Bassett, researcher Michael Hendryx, and neuroscientist Rachel Wurzman.
Now Playing: Science for the People

#544 Prosperity Without Growth
The societies we live in are organised around growth, objects, and driving forward a constantly expanding economy as benchmarks of success and prosperity. But this growing consumption at all costs is at odds with our understanding of what our planet can support. How do we lower the environmental impact of economic activity? How do we redefine success and prosperity separate from GDP, which politicians and governments have focused on for decades? We speak with ecological economist Tim Jackson, Professor of Sustainable Development at the University of Surrey, Director of the Centre for the Understanding of Sustainable Propserity, and author of...
Now Playing: Radiolab

An Announcement from Radiolab